-
2
-
-
79955510505
-
Efficacy and safety of sirolimus in lymphangioleiomyomatosis
-
McCormack FX, et al. Efficacy and safety of sirolimus in lymphangioleiomyomatosis. N Engl J Med. 2011;364(17):1595-1606.
-
(2011)
N Engl J Med
, vol.364
, Issue.17
, pp. 1595-1606
-
-
McCormack, F.X.1
-
3
-
-
78049510428
-
Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis
-
Krueger DA, et al. Everolimus for subependymal giant-cell astrocytomas in tuberous sclerosis. N Engl J Med. 2010;363(19):1801-1811.
-
(2010)
N Engl J Med
, vol.363
, Issue.19
, pp. 1801-1811
-
-
Krueger, D.A.1
-
4
-
-
38049169559
-
Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis
-
Bissler JJ, et al. Sirolimus for angiomyolipoma in tuberous sclerosis complex or lymphangioleiomyomatosis. N Engl J Med. 2008;358(2):140-151.
-
(2008)
N Engl J Med
, vol.358
, Issue.2
, pp. 140-151
-
-
Bissler, J.J.1
-
5
-
-
78650510609
-
mTOR: From growth signal integration to cancer, diabetes and ageing
-
Zoncu R, Efeyan A, Sabatini DM. mTOR: from growth signal integration to cancer, diabetes and ageing. Nat Rev Mol Cell Biol. 2011;12(1):21-35.
-
(2011)
Nat Rev Mol Cell Biol
, vol.12
, Issue.1
, pp. 21-35
-
-
Zoncu, R.1
Efeyan, A.2
Sabatini, D.M.3
-
6
-
-
78649348967
-
Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress
-
Sengupta S, Peterson TR, Sabatini DM. Regulation of the mTOR complex 1 pathway by nutrients, growth factors, and stress. Mol Cell. 2010; 40(2):310-322.
-
(2010)
Mol Cell
, vol.40
, Issue.2
, pp. 310-322
-
-
Sengupta, S.1
Peterson, T.R.2
Sabatini, D.M.3
-
7
-
-
33751348056
-
Ablation in Mice of the mTORC Components raptor, rictor, or mLST8 Reveals that mTORC2 Is Required for Signaling to Akt-FOXO and PKCalpha, but Not S6K1
-
DOI 10.1016/j.devcel.2006.10.007, PII S153458070600459X
-
Guertin DA, et al. Ablation in mice of the mTORC components raptor, rictor, or mLST8 reveals that mTORC2 is required for signaling to Akt-FOXO and PKCalpha, but not S6K1. Dev Cell. 2006; 11(6):859-871. (Pubitemid 44804279)
-
(2006)
Developmental Cell
, vol.11
, Issue.6
, pp. 859-871
-
-
Guertin, D.A.1
Stevens, D.M.2
Thoreen, C.C.3
Burds, A.A.4
Kalaany, N.Y.5
Moffat, J.6
Brown, M.7
Fitzgerald, K.J.8
Sabatini, D.M.9
-
8
-
-
33749076673
-
SIN1/MIP1 Maintains rictor-mTOR Complex Integrity and Regulates Akt Phosphorylation and Substrate Specificity
-
DOI 10.1016/j.cell.2006.08.033, PII S0092867406011470
-
Jacinto E, et al. SIN1/MIP1 maintains rictor- mTOR complex integrity and regulates Akt phosphorylation and substrate specificity. Cell. 2006; 127(1):125-137. (Pubitemid 44466632)
-
(2006)
Cell
, vol.127
, Issue.1
, pp. 125-137
-
-
Jacinto, E.1
Facchinetti, V.2
Liu, D.3
Soto, N.4
Wei, S.5
Jung, S.Y.6
Huang, Q.7
Qin, J.8
Su, B.9
-
9
-
-
54849431380
-
Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration
-
Polak P, Cybulski N, Feige JN, Auwerx J, Ruegg MA, Hall MN. Adipose-specific knockout of raptor results in lean mice with enhanced mitochondrial respiration. Cell Metab. 2008;8(5):399-410.
-
(2008)
Cell Metab
, vol.8
, Issue.5
, pp. 399-410
-
-
Polak, P.1
Cybulski, N.2
Feige, J.N.3
Auwerx, J.4
Ruegg, M.A.5
Hall, M.N.6
-
10
-
-
54849426651
-
Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy
-
Bentzinger CF, et al. Skeletal muscle-specific ablation of raptor, but not of rictor, causes metabolic changes and results in muscle dystrophy. Cell Metab. 2008;8(5):411-424.
-
(2008)
Cell Metab
, vol.8
, Issue.5
, pp. 411-424
-
-
Bentzinger, C.F.1
-
11
-
-
79960470913
-
mTOR complex 2 signaling and functions
-
Oh WJ, Jacinto E. mTOR complex 2 signaling and functions. Cell Cycle. 2011;10(14):2305-2316.
-
(2011)
Cell Cycle
, vol.10
, Issue.14
, pp. 2305-2316
-
-
Oh, W.J.1
Jacinto, E.2
-
12
-
-
80655130327
-
Autophagy: An 'Achilles' heel of tumorigenesis in TSC and LAM
-
Yu J, Parkhitko A, Henske EP. Autophagy: an 'Achilles' heel of tumorigenesis in TSC and LAM. Autophagy. 2011;7(11):1400-1401.
-
(2011)
Autophagy
, vol.7
, Issue.11
, pp. 1400-1401
-
-
Yu, J.1
Parkhitko, A.2
Henske, E.P.3
-
13
-
-
78649704325
-
Autophagy and metabolism
-
Rabinowitz JD, White E. Autophagy and metabolism. Science. 2010;330(6009):1344-1348.
-
(2010)
Science
, vol.330
, Issue.6009
, pp. 1344-1348
-
-
Rabinowitz, J.D.1
White, E.2
-
14
-
-
79961059959
-
Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent
-
Parkhitko A, et al. Tumorigenesis in tuberous sclerosis complex is autophagy and p62/sequestosome 1 (SQSTM1)-dependent. Proc Natl Acad Sci U S A. 2011;108(30):12455-12460.
-
(2011)
Proc Natl Acad Sci U S A
, vol.108
, Issue.30
, pp. 12455-12460
-
-
Parkhitko, A.1
-
15
-
-
84861833364
-
mTORC1 is essential for leukemia propagation but not stem cell self-renewal
-
Hoshii T, et al. mTORC1 is essential for leukemia propagation but not stem cell self-renewal. J Clin Invest. 2012;122(6):2114-2129.
-
(2012)
J Clin Invest
, vol.122
, Issue.6
, pp. 2114-2129
-
-
Hoshii, T.1
-
16
-
-
79960271775
-
Targeting the translational apparatus to improve leukemia therapy: Roles of the PI3K/PTEN/Akt/mTOR pathway
-
Martelli AM, et al. Targeting the translational apparatus to improve leukemia therapy: roles of the PI3K/PTEN/Akt/mTOR pathway. Leukemia. 2011;25(7):1064-1079.
-
(2011)
Leukemia
, vol.25
, Issue.7
, pp. 1064-1079
-
-
Martelli, A.M.1
-
17
-
-
79959611236
-
NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia
-
Guo D, Teng Q, Ji C. NOTCH and phosphatidylinositide 3-kinase/phosphatase and tensin homolog deleted on chromosome ten/AKT/mammalian target of rapamycin (mTOR) signaling in T-cell development and T-cell acute lymphoblastic leukemia. Leuk Lymphoma. 2011;52(7):1200-1210.
-
(2011)
Leuk Lymphoma
, vol.52
, Issue.7
, pp. 1200-1210
-
-
Guo, D.1
Teng, Q.2
Ji, C.3
-
18
-
-
80555154901
-
Targeting mTOR for the treatment of AML. New agents and new directions
-
Altman JK, Sassano A, Platanias LC. Targeting mTOR for the treatment of AML. New agents and new directions. Oncotarget. 2011;2(6):510-517.
-
(2011)
Oncotarget
, vol.2
, Issue.6
, pp. 510-517
-
-
Altman, J.K.1
Sassano, A.2
Platanias, L.C.3
-
19
-
-
82555166000
-
mTOR signaling in disease
-
Dazert E, Hall MN. mTOR signaling in disease. Curr Opin Cell Biol. 2011;23(6):744-755.
-
(2011)
Curr Opin Cell Biol
, vol.23
, Issue.6
, pp. 744-755
-
-
Dazert, E.1
Hall, M.N.2
-
20
-
-
80155142474
-
Rapamycin passes the torch: A new generation of mTOR inhibitors
-
Benjamin D, Colombi M, Moroni C, Hall MN. Rapamycin passes the torch: a new generation of mTOR inhibitors. Nat Rev Drug Discov. 2011; 10(11):868-880.
-
(2011)
Nat Rev Drug Discov
, vol.10
, Issue.11
, pp. 868-880
-
-
Benjamin, D.1
Colombi, M.2
Moroni, C.3
Hall, M.N.4
-
21
-
-
84856800302
-
Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: Cross talk, shortcuts, and feedbacks
-
Alers S, Loffler AS, Wesselborg S, Stork B. Role of AMPK-mTOR-Ulk1/2 in the regulation of autophagy: cross talk, shortcuts, and feedbacks. Mol Cell Biol. 2012;32(1):2-11.
-
(2012)
Mol Cell Biol
, vol.32
, Issue.1
, pp. 2-11
-
-
Alers, S.1
Loffler, A.S.2
Wesselborg, S.3
Stork, B.4
|